Submit Deal

GSK PLC

Summary

GSK is a global biopharmaceutical company focused on science, technology, and talent to prevent and treat disease.

Deals Overview

Total Deals4

Valued Deals3

Total Value£ 3.30 B

Avg. Deal Size£ 1.10 B

Market Context

Senior Management

Tony Wood
Chief Scientific Officer

Sort

15 Jan 2025|Germany|Biotechnology

Target: CELLPHENOMICS GMBH

Bidder: GSK PLC

1 Service Providers

1 Bidder

8 Dealmakers

8 Bidder

n/a

Value

10 Jan 2025|United States|Biotechnology

Target: OURO MEDICINES

Bidder: GSK PLC

10 Service Providers

2 Target | 8 Bidder

14 Dealmakers

6 Target | 9 Bidder

£ 97 M

Value

20 Jan 2026|United Kingdom|Pharmaceuticals

Target: VIIV HEALTHCARE

Bidder: SHIONOGI

3 Service Providers

1 Target | 1 Bidder | 1 Vendor

9 Dealmakers

1 Target | 1 Bidder | 7 Vendor

£ 1.56 B

Value

20 Jan 2026|United States|Pharmaceuticals

Target: RAPT THERAPEUTICS

Bidder: GSK PLC

6 Service Providers

3 Target | 3 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 1.64 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy